Yamin Khan, hVIVO CEO
July 17, 2024 11:09 AM EDTUpdated 01:14 PM
Deals
Outsourcing

‘Search mode’: Hu­man chal­lenge tri­al com­pa­ny looks to buy small CROs

Anna Brown

News Reporter

LON­DON – Vi­ral chal­lenge study ser­vice provider hVI­VO is in “search mode” to buy small con­tract re­search or­ga­ni­za­tions (CROs) to help reach its goal of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times